Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Latest filing published 14 Mar 2023 for Mendus AB, €1,708. Read the official filing
Filing timeline
BuySaleSven Arne Andreasson
Insider track record
Disclosed buys
1
Disclosed sells
2
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sven Arne Andreasson: trading record in brief
Filings by Sven Arne Andreasson span 2 companies, the busiest being Mendus AB and Immunicum AB. In total, 3 filings cover trades dated from 2 April 2021 to 25 October 2022.
Both buying and selling appear: 1 purchase worth €15k, against 2 sales worth €4,629. Netting one side against the other leaves €9,979 of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2023 to date brings no purchases and 2 sales.
The newest entry dates from 14 March 2023: an open-market sale of €1,708, in Mendus AB. The last insider purchase was made public on 27 April 2021, 2,002 days ago. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Sven Arne Andreasson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,000 shares@ SEK 1.884.1% of flowAktieISIN SE0005003654FI:csv-13ed04bf6df82f4833f6
15,000 shares@ SEK 2.137.1% of flowAktieISIN SE0005003654FI:csv-ed1baa2cdc29d585a74f
25,000 shares@ SEK 6.00100.0% of flowAktieISIN SE0005003654FI:csv-14b141164ac5963bedcd
Canonical exit: 1 Jul 2021 (T+90)
3 of 3 declarations
